Literature DB >> 21701018

Reproducibility of perfusion parameters obtained from perfusion CT in lung tumors.

Chaan S Ng1, Adam G Chandler, Wei Wei, Ella F Anderson, Delise H Herron, Chusilp Charnsangavej, Razelle Kurzrock.   

Abstract

OBJECTIVE: The purpose of this article is to assess the variability of perfusion CT measurements in lung tumors and the effects of motion and duration of data acquisition on perfusion CT parameter values. SUBJECTS AND METHODS: Two perfusion CT scans were obtained in 11 patients with lung tumors, 2-7 days apart, using phase 1 scans (30-second breath-hold cine) followed by phase 2 scans (six intermittent helical breath-holds), spanning 125 seconds. Tumor blood flow (BF), blood volume (BV), mean transit time (MTT), and permeability were calculated for phase 1 using all-cine and motion-corrected (rigidly registered) images, both with and without matching phase 2 images (manually or rigidly registered). Variability was assessed by the within-patient coefficient of variation (CV) and Bland-Altman analyses.
RESULTS: BF, BV, MTT, and permeability values varied widely by method of analysis (median BF, 45.3-65.1 mL/min/100 g; median BV, 2.6-3.8 mL/100 g; median MTT, 3.6-4.1 seconds, and median permeability, 13.7-39.3 mL/min/100 g), as did within-patient CVs (10.9-114.4%, 25.3-117.6%, 22.3-51.5%, and 29.6-134.9%, respectively). Parameter values and variability were affected by motion and duration of data analyzed: permeability values doubled when phase 2 images were added to phase 1 data. Overall, the best reproducibility was obtained with registered phase 1 and 2 data, with within-patient CVs of 11.6%, 26.5%, 45.4%, and 30.2%, respectively.
CONCLUSION: The absolute values and reproducibility of perfusion parameters in lung tumors are markedly influenced by motion and duration of data acquisition. Permeability, in particular, probably requires data acquisition beyond a single breath-hold. The smallest variability in parameter values was obtained with motion correction and extended acquisition durations.

Entities:  

Mesh:

Year:  2011        PMID: 21701018     DOI: 10.2214/AJR.10.5404

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  20 in total

1.  Dynamic contrast-enhanced CT in suspected lung cancer: quantitative results.

Authors:  S W Harders; H H Madsen; H M Nellemann; T R Rasmussen; J Thygesen; H Hager; N T Andersen; F Rasmussen
Journal:  Br J Radiol       Date:  2013-09-12       Impact factor: 3.039

2.  Assessment of prostate cancer with integrated CT-perfusion using a sector-wise approach.

Authors:  Matteo Ferrari; Martin Huellner; Chantal Pauli; Burkhardt Seifert; Hansjörg Danuser; Patrick Veit-Haibach; Agostino Mattei
Journal:  Turk J Urol       Date:  2017-05-03

3.  Effect of pre-enhancement set point on computed tomographic perfusion values in normal liver and metastases to the liver from neuroendocrine tumors.

Authors:  Chaan S Ng; Adam G Chandler; James C Yao; Delise H Herron; Ella F Anderson; Chusilp Charnsangavej; Brian P Hobbs
Journal:  J Comput Assist Tomogr       Date:  2014 Jul-Aug       Impact factor: 1.826

4.  Effect on perfusion values of sampling interval of computed tomographic perfusion acquisitions in neuroendocrine liver metastases and normal liver.

Authors:  Chaan S Ng; Brian P Hobbs; Wei Wei; Ella F Anderson; Delise H Herron; James C Yao; Adam G Chandler
Journal:  J Comput Assist Tomogr       Date:  2015 May-Jun       Impact factor: 1.826

5.  Is liver perfusion CT reproducible? A study on intra- and interobserver agreement of normal hepatic haemodynamic parameters obtained with two different software packages.

Authors:  Elisa Almeida Sathler Bretas; Ulysses S Torres; Lucas Rios Torres; Daniel Bekhor; Celso Fernando Saito Filho; Douglas Jorge Racy; Lorenzo Faggioni; Giuseppe D'Ippolito
Journal:  Br J Radiol       Date:  2017-08-22       Impact factor: 3.039

6.  Metastases to the liver from neuroendocrine tumors: effect of duration of scan acquisition on CT perfusion values.

Authors:  Chaan S Ng; Brian P Hobbs; Adam G Chandler; Ella F Anderson; Delise H Herron; Chusilp Charnsangavej; James Yao
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

7.  Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer.

Authors:  P Veit-Haibach; D De Ruysscher; W van Elmpt; M Das; Martin Hüllner; H Sharifi; K Zegers; B Reymen; P Lambin; J E Wildberger; E G C Troost
Journal:  Radiother Oncol       Date:  2013-09-14       Impact factor: 6.280

8.  Uncertainty analysis of quantitative imaging features extracted from contrast-enhanced CT in lung tumors.

Authors:  Jinzhong Yang; Lifei Zhang; Xenia J Fave; David V Fried; Francesco C Stingo; Chaan S Ng; Laurence E Court
Journal:  Comput Med Imaging Graph       Date:  2015-12-14       Impact factor: 4.790

9.  CT perfusion imaging of lung cancer: benefit of motion correction for blood flow estimates.

Authors:  Lisa L Chu; Robert J Knebel; Aryan D Shay; Jonathan Santos; Ramsey D Badawi; David R Gandara; Friedrich D Knollmann
Journal:  Eur Radiol       Date:  2018-06-04       Impact factor: 5.315

Review 10.  State of the art: Response assessment in lung cancer in the era of genomic medicine.

Authors:  Mizuki Nishino; Hiroto Hatabu; Bruce E Johnson; Theresa C McLoud
Journal:  Radiology       Date:  2014-04       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.